HK1104175A1 - Pyrrolopyridine derivatives - Google Patents

Pyrrolopyridine derivatives

Info

Publication number: HK1104175A1
Authority: HK; Hong Kong
Prior art keywords: pyrrolopyridine derivatives; pyrrolopyridine; derivatives
Prior art date: 2004-06-09

Application number

HK07108940.7A

Other languages

English (en)

Inventor

Andrew John Eatherton

Matthew Russell Johnson

Alcide Perboni

Gerard Martin Paul Giblin

William Leonard Mitchell

Brian Peter Slingsby

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-09

Filing date

2007-08-16

Publication date

2008-01-04

2004-06-09 Priority claimed from GB0412908A external-priority patent/GB0412908D0/en

2004-11-11 Priority claimed from GB0424950A external-priority patent/GB0424950D0/en

2007-08-16 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2008-01-04 Publication of HK1104175A1 publication Critical patent/HK1104175A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

HK07108940.7A 2004-06-09 2007-08-16 Pyrrolopyridine derivatives HK1104175A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0412908A GB0412908D0 (en)	2004-06-09	2004-06-09	Compounds
GB0424950A GB0424950D0 (en)	2004-11-11	2004-11-11	Compounds
PCT/EP2005/006182 WO2005121140A1 (fr)	2004-06-09	2005-06-07	Derives de pyrrolopyridine

Publications (1)

Publication Number	Publication Date
HK1104175A1 true HK1104175A1 (en)	2008-01-04

Family

ID=34969264

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK07108940.7A HK1104175A1 (en)	2004-06-09	2007-08-16	Pyrrolopyridine derivatives

Country Status (26)

Country	Link
US (1)	US7589206B2 (fr)
EP (1)	EP1753764B1 (fr)
JP (1)	JP2008501758A (fr)
KR (1)	KR20070034049A (fr)
AR (1)	AR050158A1 (fr)
AT (1)	ATE412651T1 (fr)
AU (1)	AU2005251913A1 (fr)
BR (1)	BRPI0511874A (fr)
CA (1)	CA2569887A1 (fr)
DE (1)	DE602005010698D1 (fr)
DK (1)	DK1753764T3 (fr)
ES (1)	ES2317244T3 (fr)
HK (1)	HK1104175A1 (fr)
HR (1)	HRP20090034T3 (fr)
IL (1)	IL179603A0 (fr)
MA (1)	MA28686B1 (fr)
MX (1)	MXPA06014471A (fr)
NO (1)	NO20070067L (fr)
PE (1)	PE20060430A1 (fr)
PL (1)	PL1753764T3 (fr)
PT (1)	PT1753764E (fr)
RU (1)	RU2006147278A (fr)
SI (1)	SI1753764T1 (fr)
TW (1)	TW200611695A (fr)
UY (1)	UY28945A1 (fr)
WO (1)	WO2005121140A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2533369C (fr)	2003-07-22	2009-07-14	Arena Pharmaceuticals, Inc.	Derives de diaryl et arylheteroaryl uree utilises en tant que modulateurs du recepteur de la serotonine 5-ht2a utiles pour la prophylaxie et le traitement de troubles associes a ce dernier
ATE412651T1 (de)	2004-06-09	2008-11-15	Glaxo Group Ltd	Pyrrolopyridinderivate
JP4977465B2 (ja) *	2004-07-28	2012-07-18	武田薬品工業株式会社	ピロロ［２，３−ｃ］ピリジン化合物、その製造方法および用途
KR100958830B1 (ko) *	2004-09-03	2010-05-24	주식회사유한양행	피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
US20080221097A1 (en) *	2005-08-09	2008-09-11	Glaxo Group Limited	Imidazopyridine Derivatives as Cannabinoid Receptor Ligands
GB0516379D0 (en) *	2005-08-09	2005-09-14	Glaxo Group Ltd	Compounds
US20090275611A1 (en) *	2006-04-07	2009-11-05	Boehringer Ingelheim International Gmbh	Compounds Which Modulate The CB2 Receptor
WO2008113818A1 (fr) *	2007-03-21	2008-09-25	Glaxo Group Limited	Utilisation de composés pour le traitement de la douleur et du syndrome du côlon irritable
GB0705803D0 (en) *	2007-03-28	2007-05-02	Glaxo Group Ltd	Novel compounds
WO2009074607A1 (fr)	2007-12-12	2009-06-18	Glaxo Group Limited	Associations contenant de la 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
US20110021538A1 (en)	2008-04-02	2011-01-27	Arena Pharmaceuticals, Inc.	Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
US9126946B2 (en)	2008-10-28	2015-09-08	Arena Pharmaceuticals, Inc.	Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
MX2011010396A (es)	2009-03-30	2011-10-24	Astellas Pharma Inc	Compuesto de pirimidina.
TW201200518A (en) *	2010-03-10	2012-01-01	Kalypsys Inc	Heterocyclic inhibitors of histamine receptors for the treatment of disease
CN103038218B (zh) *	2010-07-29	2016-04-13	安斯泰来制药株式会社	稠环吡啶化合物
EP2827846B1 (fr) *	2012-03-19	2020-08-12	Sharon Anavi-Goffer	Traitement de la schizophrénie à l'aide de bêta-caryophyllène et d'agonistes du récepteur cb2
SG10201802444XA (en)	2013-06-26	2018-05-30	Abbvie Inc	Primary carboxamides as btk inhibitors
EP3307260A4 (fr)	2015-06-12	2019-02-13	Axovant Sciences GmbH	Dérivés de diaryl et arylhétéroaryl urée utiles pour la prophylaxie et le traitement du trouble du comportement en sommeil rem
TW201720439A (zh)	2015-07-15	2017-06-16	Axovant Sciences Gmbh	用於預防及治療與神經退化性疾病相關的幻覺之作為５－ｈｔ２ａ血清素受體的二芳基及芳基雜芳基脲衍生物
CA3120866A1 (fr) *	2018-11-30	2020-06-04	Nimbus Lakshmi, Inc.	Inhibiteurs de tyk2 et leurs utilisations
US11891394B1 (en)	2023-09-06	2024-02-06	King Faisal University	Pyrrolo[2,3-c][1,6]naphthyridine-8-carboxylic acid compounds as CK2 inhibitors
US11858935B1 (en)	2023-09-06	2024-01-02	King Faisal University	Pyrrolo[2,3-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0113245B1 (fr) *	1982-12-29	1989-03-15	Kureha Kagaku Kogyo Kabushiki Kaisha	Dérivés de céphalosporine
CA2031927A1 (fr)	1989-12-27	1991-06-28	Imperial Oil Limited	Methode d'amelioration du maintien de l'activite d'une molecule initiatrice de plasma
WO1991009598A1 (fr)	1990-01-05	1991-07-11	Pfizer Inc.	Derives de l'azaoxindole
US5112820A (en) *	1990-03-05	1992-05-12	Sterling Drug Inc.	Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
GB9109246D0 (en)	1991-04-30	1991-06-19	Ici Plc	Nitrogen derivatives
DE4129603A1 (de)	1991-09-06	1993-03-11	Thomae Gmbh Dr K	Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
TW263504B (fr)	1991-10-03	1995-11-21	Pfizer
FR2692575B1 (fr) *	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5468757A (en)	1994-01-31	1995-11-21	Eli Lilly And Company	6-azaindole thromboxane synthase inhibitors
DK0745083T3 (da)	1994-02-18	1999-01-25	Boehringer Ingelheim Pharma	2-Heteroaryl-5, 11-dihydro-6H-dipyrido[3, 2-b:2', 3'-e][1, 4]diazepiner og deres anvendelse til forebyggelse eller behandli
GB9420521D0 (en)	1994-10-12	1994-11-30	Smithkline Beecham Plc	Novel compounds
US5589482A (en)	1994-12-14	1996-12-31	Pfizer Inc.	Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
JPH0920779A (ja)	1995-05-01	1997-01-21	Japan Tobacco Inc	縮合ヘテロ５員環アゼピン化合物類及びその医薬用途
GB9610811D0 (en)	1996-05-23	1996-07-31	Pharmacia Spa	Combinatorial solid phase synthesis of a library of indole derivatives
US6696448B2 (en)	1996-06-05	2004-02-24	Sugen, Inc.	3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
US6184235B1 (en)	1996-08-14	2001-02-06	Warner-Lambert Company	2-phenyl benzimidazole derivatives as MCP-1 antagonists
TWI242011B (en)	1997-03-31	2005-10-21	Eisai Co Ltd	1,4-substituted cyclic amine derivatives
WO1998050356A1 (fr)	1997-05-07	1998-11-12	Sugen, Inc.	Derives de 2-indolinone utilises en tant que modulateurs de l'activite de la proteine kinase
ATE237023T1 (de)	1998-01-23	2003-04-15	Voith Paper Patent Gmbh	Verfahren zur entfernung von feinen verunreinigungen aus einer faserstoffsuspension
US6232320B1 (en)	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
EP1117397A1 (fr)	1998-08-31	2001-07-25	Sugen, Inc.	Derives de 2-indolinone a geometrie limitee utilises en tant que modulateurs de l'activite de la proteine kinase
GB9904995D0 (en)	1999-03-04	1999-04-28	Glaxo Group Ltd	Substituted aza-oxindole derivatives
JP2002538205A (ja)	1999-03-10	2002-11-12	メルクエンドカムパニーインコーポレーテッド	性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
AU3868800A (en)	1999-03-10	2000-09-28	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
CA2366615A1 (fr)	1999-03-10	2000-09-14	Merck & Co., Inc.	Composes 6-azaindole utilises comme antagonistes d'une hormone liberant la gonadotropine
AU3868900A (en)	1999-03-10	2000-09-28	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
CA2367126A1 (fr)	1999-03-10	2000-09-14	Merck & Co., Inc.	Composes de 6-azaindole comme antagonistes de la gonadoliberine
JP2002538208A (ja)	1999-03-10	2002-11-12	メルクエンドカムパニーインコーポレーテッド	性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
BR9916746A (pt)	1999-06-03	2005-01-11	Abbott Lab	Compostos anti-inflamatórios que inibem adesão de célula
WO2000075145A1 (fr)	1999-06-03	2000-12-14	Abbott Laboratories	Composes anti-inflammatoires inhibant l'adhesion cellulaire
WO2001058869A2 (fr)	2000-02-11	2001-08-16	Bristol-Myers Squibb Company	Modulateurs de recepteurs aux cannabinoides, leurs procedes de preparation et utilisations de modulateurs de recepteurs aux cannabinoides pour le traitement de maladies respiratoires et non respiratoires
US20020061892A1 (en)	2000-02-22	2002-05-23	Tao Wang	Antiviral azaindole derivatives
EP1132389A1 (fr)	2000-03-06	2001-09-12	Vernalis Research Limited	Nouveaux dérivés de l'azaindole pour le traitement de l'obésité
KR20030024661A (ko)	2000-04-28	2003-03-26	박스터 헬쓰케어 에스.에이.	2-아실 인돌 유도체 및 항종양제로서의 이의 용도
AU2001259190B2 (en)	2000-04-28	2007-01-25	Acadia Pharmaceuticals, Inc.	Muscarinic agonists
DE60119124T2 (de)	2000-08-14	2006-11-30	Ortho-Mcneil Pharmaceutical, Inc.	Substituierte pyrazole
US7332494B2 (en)	2000-08-14	2008-02-19	Janssen Pharmaceutica, N.V.	Method for treating allergies using substituted pyrazoles
US7342016B2 (en)	2000-08-30	2008-03-11	Schering Corporation	Farnesyl protein transferase inhibitors as antitumor agents
JP2004523469A (ja)	2000-09-06	2004-08-05	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	アレルギーの治療方法
AU8873101A (en)	2000-09-06	2002-03-22	Ortho Mcneil Pharm Inc	A method for treating allergies using substituted pyrazoles
WO2002028831A1 (fr)	2000-10-02	2002-04-11	Merck & Co., Inc.	Inhibiteurs de la prenyl-proteine transferase
US6958358B2 (en)	2001-01-17	2005-10-25	Amura Therapeutics Limited	Inhibitors of cruzipain and other cysteine proteases
US20030207910A1 (en)	2001-02-02	2003-11-06	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
RS52489B (en)	2001-02-02	2013-02-28	Bristol-Myers Squibb Company	COMPOSITION AND ANTI-VIRUS ACTIVITY OF DERIVATIVES OF SUBSTITUTED AZAINDOLOXSOACETATE PIPERAZINE
US6951848B2 (en)	2001-03-12	2005-10-04	Millennium Pharmaceuticals, Inc.,	Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
EP1767525A1 (fr)	2001-04-09	2007-03-28	Novartis Vaccines and Diagnostics, Inc.	Composés guanidino comme agonistes du récepteur 4 de la mélanocortine (MC4-R)
EP1392309B1 (fr)	2001-05-14	2007-01-17	Bristol-Myers Squibb Company	Pyrazinones, pyridines et pyrimidines substitues en tant que ligands de la corticoliberine
AR035543A1 (es)	2001-06-26	2004-06-16	Japan Tobacco Inc	Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
WO2003009852A1 (fr)	2001-07-24	2003-02-06	Merck & Co., Inc.	Inhibiteurs de tyrosine kinase
DE10143079A1 (de)	2001-09-03	2003-05-15	Zentaris Ag	Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel
AU2002336462A1 (en)	2001-09-06	2003-03-24	Millennium Pharmaceuticals, Inc.	Piperazine and homopiperazine compounds
ES2278064T3 (es)	2001-10-19	2007-08-01	Transtech Pharma Inc.	Derivados de beta-carbolina como inhibidores de ptp.
DE10152306A1 (de)	2001-10-26	2003-07-24	Asta Medica Ag	2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
TW200301251A (en)	2001-12-20	2003-07-01	Wyeth Corp	Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
US20030236277A1 (en)	2002-02-14	2003-12-25	Kadow John F.	Indole, azaindole and related heterocyclic pyrrolidine derivatives
ATE346068T1 (de)	2002-03-27	2006-12-15	Glaxo Group Ltd	Chinolin- und aza-indolderivate und deren verwendung als 5-ht6 liganden
AU2003224257A1 (en)	2002-04-09	2003-10-27	Astex Technology Limited	Heterocyclic compounds and their use as modulators of p38 map kinase
US20040063744A1 (en)	2002-05-28	2004-04-01	Tao Wang	Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
UA78999C2 (en)	2002-06-04	2007-05-10	Wyeth Corp	1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
US6900206B2 (en)	2002-06-20	2005-05-31	Bristol-Myers Squibb Company	Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
TW200403243A (en)	2002-07-18	2004-03-01	Wyeth Corp	1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
US7427616B2 (en)	2002-08-06	2008-09-23	Astrazeneca Ab	Condensed pyridines and pyrimidines with tie2 (TEK) activity
AU2003260436A1 (en)	2002-08-21	2004-03-11	Glaxo Group Limited	Pyrimidine compounds
GB0222493D0 (en)	2002-09-27	2002-11-06	Glaxo Group Ltd	Compounds
EA200500584A1 (ru)	2002-09-30	2006-02-24	Дженелэбс Текнолоджиз, Инк.	Нуклеозидные производные для лечения инфекционных заболеваний, вызванных вирусом гепатита c
FR2845388B1 (fr)	2002-10-08	2004-11-12	Sanofi Synthelabo	Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
AU2004213375A1 (en)	2003-02-14	2004-09-02	Wyeth	Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-Hydroxytryptamine-6 ligands
US20040214856A1 (en)	2003-04-23	2004-10-28	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
ATE412651T1 (de)	2004-06-09	2008-11-15	Glaxo Group Ltd	Pyrrolopyridinderivate

2005
- 2005-06-07 AT AT05747418T patent/ATE412651T1/de not_active IP Right Cessation
- 2005-06-07 WO PCT/EP2005/006182 patent/WO2005121140A1/fr active Application Filing
- 2005-06-07 JP JP2007526300A patent/JP2008501758A/ja not_active Withdrawn
- 2005-06-07 KR KR1020077000449A patent/KR20070034049A/ko not_active Application Discontinuation
- 2005-06-07 DK DK05747418T patent/DK1753764T3/da active
- 2005-06-07 UY UY28945A patent/UY28945A1/es unknown
- 2005-06-07 PL PL05747418T patent/PL1753764T3/pl unknown
- 2005-06-07 AU AU2005251913A patent/AU2005251913A1/en not_active Abandoned
- 2005-06-07 PE PE2005000651A patent/PE20060430A1/es not_active Application Discontinuation
- 2005-06-07 BR BRPI0511874-3A patent/BRPI0511874A/pt not_active IP Right Cessation
- 2005-06-07 EP EP05747418A patent/EP1753764B1/fr active Active
- 2005-06-07 DE DE602005010698T patent/DE602005010698D1/de active Active
- 2005-06-07 SI SI200530497T patent/SI1753764T1/sl unknown
- 2005-06-07 RU RU2006147278/04A patent/RU2006147278A/ru not_active Application Discontinuation
- 2005-06-07 ES ES05747418T patent/ES2317244T3/es active Active
- 2005-06-07 AR ARP050102327A patent/AR050158A1/es unknown
- 2005-06-07 US US11/570,099 patent/US7589206B2/en not_active Expired - Fee Related
- 2005-06-07 MX MXPA06014471A patent/MXPA06014471A/es unknown
- 2005-06-07 TW TW094118669A patent/TW200611695A/zh unknown
- 2005-06-07 CA CA002569887A patent/CA2569887A1/fr not_active Abandoned
- 2005-06-07 PT PT05747418T patent/PT1753764E/pt unknown
2006
- 2006-11-27 IL IL179603A patent/IL179603A0/en unknown
- 2006-12-28 MA MA29569A patent/MA28686B1/fr unknown
2007
- 2007-01-04 NO NO20070067A patent/NO20070067L/no not_active Application Discontinuation
- 2007-08-16 HK HK07108940.7A patent/HK1104175A1/xx not_active IP Right Cessation
2009
- 2009-01-20 HR HR20090034T patent/HRP20090034T3/xx unknown

Also Published As

Publication number	Publication date
UY28945A1 (es)	2006-01-31
EP1753764B1 (fr)	2008-10-29
BRPI0511874A (pt)	2008-01-15
ATE412651T1 (de)	2008-11-15
EP1753764A1 (fr)	2007-02-21
JP2008501758A (ja)	2008-01-24
IL179603A0 (en)	2007-05-15
US7589206B2 (en)	2009-09-15
PL1753764T3 (pl)	2009-04-30
RU2006147278A (ru)	2008-07-20
SI1753764T1 (sl)	2009-02-28
HRP20090034T3 (en)	2009-03-31
DE602005010698D1 (de)	2008-12-11
TW200611695A (en)	2006-04-16
NO20070067L (no)	2007-02-09
PT1753764E (pt)	2009-01-28
WO2005121140A1 (fr)	2005-12-22
US20070219229A1 (en)	2007-09-20
ES2317244T3 (es)	2009-04-16
KR20070034049A (ko)	2007-03-27
AR050158A1 (es)	2006-10-04
CA2569887A1 (fr)	2005-12-22
MA28686B1 (fr)	2007-06-01
MXPA06014471A (es)	2007-03-21
AU2005251913A1 (en)	2005-12-22
PE20060430A1 (es)	2006-05-25
DK1753764T3 (da)	2009-02-16

Publication	Publication Date	Title
HK1104175A1 (en)	2008-01-04	Pyrrolopyridine derivatives
IL180481A0 (en)	2007-06-03	Aryl-pyridine derivatives
IL177968A0 (en)	2006-12-31	Tetrahydropyridoindole derivatives
IL179736A0 (en)	2007-05-15	Pyrrazolo-pyrimidine derivatives
IL180331A0 (en)	2007-07-04	3-carbamoyl - 2 - pyridone derivative
HK1105966A1 (en)	2008-02-29	New 4-benzylidene-piperidin derivatives
IL183140A0 (en)	2007-09-20	Substituted benzoquinolizine derivatives
IL182585A0 (en)	2007-07-24	Imidazo-benzodiazepine derivatives
HK1101638A1 (en)	2007-10-18	New pyridothienopyrimidine derivatives
HK1100002A1 (en)	2007-08-31	4-phenyl-pyrimidine-2-carbonitrile derivatives
IL183141A0 (en)	2007-09-20	New pyridothienopyrimidine derivatives
HK1100775A1 (en)	2007-09-28	4-Amino-5-cyanopyrimidine derivatives
GB0414272D0 (en)	2004-07-28	OsK1 derivatives
IL178774A0 (en)	2007-02-11	Imidazopyridine compound
IL182001A0 (en)	2007-07-04	2-acylaminothiazole derivatives
ZA200609864B (en)	2008-08-27	Pyrrolopyridine derivatives
GB0422398D0 (en)	2004-11-10	Pyridopyrimidine derivatives
GB0422397D0 (en)	2004-11-10	3-Cyano-Quinoline derivatives
GB0405905D0 (en)	2004-04-21	Azaquinazoline derivatives
GB0422395D0 (en)	2004-11-10	Pyrimidopyrimidine derivatives

Legal Events

Date	Code	Title	Description
2014-01-03	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20130607